Group 1: Market Trends - Significant style shift in overseas stock markets, particularly in the U.S., with value stocks outperforming growth stocks[5] - As of February 20, the value long/short hedge fund strategy index rose by 9.7%, while the growth long/short hedge fund strategy index fell by 1.6%, resulting in a performance gap exceeding 10%[7] - The equal-weighted S&P 500 index's monthly performance difference compared to the market-cap weighted S&P 500 index reached 3.4%, the highest level since 2010[16] Group 2: Risk and Returns - The equity risk premium (ERP) for the CSI 300 index was 4.2% as of February 13, which is one standard deviation below the 16-year average, indicating potential for valuation uplift[19] - The forward arbitrage return for China's 10-year government bonds was 29 basis points, 59 basis points higher than the level in December 2016[21] - The total return ratio of domestic stocks to bonds was 28.7 as of February 13, above the 16-year average, suggesting increased attractiveness of equity assets relative to fixed income[29] Group 3: Currency and Commodity Indicators - The copper-gold price ratio reached 2.5 as of February 20, indicating a convergence with the offshore RMB exchange rate of 6.9, suggesting alignment in signals from both indicators[27] - The 3-month USD/JPY basis swap was -16.8 basis points as of February 20, indicating increased offshore dollar financing pressure relief due to higher usage of the Fed's standing repo facility[24]

证券研究报 告 宏观研究 【每周经济观察】 春节假期海外四大要闻——海外周报第 128 期 1、股市：全球主要股指多数上涨，韩股、法股、英股涨幅领先。2 月 16 日 ~20日，韩国综合指数、法国 CAC40、富时 100、欧洲斯托克 600指数、纳斯 达克、德国 DAX、标普 500、MSCI 新兴市场指数和道琼斯分别上涨 5.5%、 2.5%、2.3%、2.1%、1.5%、1.4%、1.1%、1.0%、 0.8%和 0.3%；恒生指数和 日经 225 分别下跌 0.6%和 0.2%。 2、债券：除美债利率外，全球主要 10 年期国债收益率多数下行。2 月 16 日 ~20 日，10 年期日债、法债、英债和意债收益率分别下行 6.1bps、3.8bps、 2.7bps 和 2.3bps；10 年期美债收益率上行 4.0bps。 3、大宗：全球主要大宗商品多数上涨。2 月 16 日~20 日，布伦特原油、WTI 原油、伦敦现货白银、伦敦现货黄金和 LME 期铜分别上涨 5.9%、5.7%、 4.1%、1.2%和 0.0%。 4、汇率：主要货币中日元、英镑跌幅较大。2 月 16 日~20 日，日元和英镑分 别下 ...

Investment Rating - The report maintains a "Recommendation" rating for the aviation industry, expecting the industry index to outperform the benchmark index by more than 5% in the next 3-6 months [47]. Core Insights - The Spring Festival travel season has seen a record high in cross-regional personnel flow, with an estimated total of 5.08 billion trips in the first 20 days, averaging 250 million trips per day, which is a 5.6% increase compared to the same period in 2025 [9][10]. - The aviation sector has shown strong performance in both passenger volume and ticket prices, with a 5.4% year-on-year increase in passenger volume and a 3.3% increase in average ticket prices during the same period [10][11]. - The 2026 Spring Festival is characterized by two main trends: "secondary travel" and "concentrated return trips," driven by a later Spring Festival and longer holiday period [12][13]. Summary by Sections Passenger Volume and Pricing - In the first 20 days of the Spring Festival, the average daily passenger volume for civil aviation reached 2.376 million, a 5.4% increase year-on-year, while the average ticket price was 1003 yuan, up 3.3% year-on-year [10][11]. - The domestic average passenger load factor was 85.1%, reflecting a 1.1% increase year-on-year, indicating strong demand [11]. Market Dynamics - Six listed airlines collectively withdrew 5 aircraft in January 2026, indicating a tightening supply constraint in the industry [26]. - The report highlights that except for Spring Airlines, all other major airlines have shown negative year-on-year growth in capacity deployment, with Spring Airlines leading at 4.5% growth [26]. Demand and Future Outlook - The demand structure in the aviation industry is improving, with a rebound in business travel sentiment since September 2025 [34]. - The introduction of visa-free policies for Canada and the UK starting February 17, 2026, is expected to boost cross-border travel demand [34]. - High passenger load factors are anticipated to lead to increased price elasticity, with the potential for significant price increases in 2026 [35]. Recommendations - The report recommends focusing on major airlines such as Air China, China Southern Airlines, and China Eastern Airlines for potential elasticity release, as well as low-cost carrier Spring Airlines for its core competitive advantages [35].

Investment Rating - The report maintains a "Recommendation" rating for the shipping industry, indicating an expectation of growth exceeding the benchmark index by more than 5% in the next 3-6 months [6]. Core Insights - The VLCC market is experiencing unprecedented high sentiment driven by geopolitical risk premiums, aggressive capacity expansion by Changjin Shipping, and strengthened sanctions [1][9]. - The geopolitical situation between the US and Iran continues to elevate risk premiums, with Brent crude oil futures reaching $71.76 per barrel, a week-on-week increase of 5.9% [2][19]. - Changjin Shipping has rapidly expanded its fleet, becoming the largest VLCC operator globally, controlling 118 VLCCs, which corresponds to a market share of 16% [2][20][21]. - Strengthened sanctions are increasing the demand for compliant trade, with Venezuela's oil shifting towards compliant markets and India committing to stop purchasing Russian oil, which could add 1% to global tanker trade [3][39]. - The EU's proposal for a comprehensive ban on maritime services for Russian oil could necessitate the transfer of more compliant vessels into shadow fleets, impacting supply dynamics [4][43]. Summary by Sections Market Review - VLCC rates have surged to their highest levels in nearly a decade, with the Clarksons VLCC-TCE reaching $142,000 per day, a week-on-week increase of 24.5% [9][12]. - The stock performance of tanker companies has been strong, with notable increases during the holiday period [16]. Geopolitical Factors - The ongoing US-Iran negotiations have not yielded clear outcomes, maintaining military tensions and affecting oil transport routes, particularly in the Strait of Hormuz [2][19]. - Changjin Shipping's aggressive market entry reflects confidence in the tanker market's high profitability, with a significant increase in the concentration of top VLCC owners [21]. Sanctions and Compliance - The report highlights a shift in the oil market towards compliance due to increased enforcement of sanctions, with Venezuela's oil exports moving towards compliant channels [3][38]. - The EU's proposed ban on maritime services for Russian oil could lead to a significant increase in the demand for compliant vessels [4][43]. Investment Recommendations - The report emphasizes a bullish outlook for the oil transportation market, with expectations of continued demand growth and limited supply, recommending specific companies within the sector [5][46].

Market Performance - Global major stock indices mostly rose, with the Korean Composite Index, French CAC40, and FTSE 100 leading with increases of 5.5%, 2.5%, and 2.3% respectively from February 16 to 20[2] - Major 10-year government bond yields mostly declined, with Japanese, French, British, and Italian bonds down by 6.1bps, 3.8bps, 2.7bps, and 2.3bps respectively, while the 10-year U.S. Treasury yield rose by 4.0bps[2] - Most major commodities saw price increases, with Brent crude oil and WTI crude oil rising by 5.9% and 5.7% respectively during the same period[2] Currency Movements - The Japanese yen and British pound experienced significant declines, falling by 1.5% and 1.3% respectively, while the U.S. dollar index rose by 0.9%[3] Geopolitical Events - The U.S.-Iran crisis escalated, with WTI crude oil prices increasing from approximately $62.33 to $66.39, marking a 6.5% rise, and Brent crude oil rising by 6.4% to $71.76 due to military tensions in the region[3] - The FOMC meeting minutes indicated a neutral yet hawkish stance, with market expectations for a potential rate cut of about 60 basis points this year, reflecting a slight easing compared to previous expectations[4] Legal and Trade Developments - The U.S. Supreme Court ruled against Trump's "emergency" tariffs, leading to a significant shift in trade policy, with Trump announcing a new 10% tariff on global imports for 150 days[5] - Following the Supreme Court's decision, the market reacted positively, with the Nasdaq index rising by 0.90% due to eased supply chain pressures[7] Economic Outlook - Japan's new Prime Minister, Fumio Kishida, emphasized a "responsible active fiscal policy," proposing significant tax cuts and public investments, which are expected to boost Japan's GDP growth forecast for 2026[8]

Policy Direction - The policy emphasizes "stability while seeking progress" and aims for a good start to the "14th Five-Year Plan" with a focus on counter-cyclical adjustments and short-term economic stability, warning against "policy dependency" without reform support[1] - Investment should not follow the old path of "rapid expansion" but focus on the real economy and technological innovation, with an emphasis on improving people's livelihoods and human resource development[2] Investment and Consumption - The government plans to optimize the implementation of "dual heavy" projects and increase central investment subsidy standards, while enhancing the management of local government special bonds to boost project construction[2] - There is a commitment to increase basic pensions for urban and rural residents and to release potential in service consumption sectors such as tourism, events, dining, and health care[3] Market Competition and Industry Development - Measures will be taken to regulate "involution-style" competition through a list of encouraged and prohibited items for local government investment, aiming to create a fair market order[3] - The focus will be on developing emerging pillar industries such as integrated circuits, aerospace, and biomedicine, while emphasizing the importance of artificial intelligence as a key variable[4] Risk Management - The report highlights the need to manage risks in key areas, including supporting reasonable financing needs of real estate companies and preventing debt default risks[9] - It calls for optimizing debt restructuring and replacement methods to mitigate risks associated with local government financing platforms[10]

Investment Rating - The industry investment rating is "Recommended" [3][45] Core Viewpoints - In January, the total slaughter volume of 18 sample pig companies increased by 12.54% year-on-year but decreased by 11.15% month-on-month, totaling 18.02 million heads [6][9] - The average selling price of commercial pigs for 15 sample pig companies in January was 12.58 yuan/kg, a year-on-year decrease of 19.30% but an increase of 8.83% month-on-month [13][14] - The average weight of slaughtered pigs in January was 121.41 kg, showing a year-on-year increase of 2.82% and a month-on-month increase of 1.42% [16][17] - The industry is experiencing a return to losses in breeding profits before the festival, with the average weight of pigs still at historically high levels [19][20] - The current valuation level of the pig farming sector is relatively low, with sufficient safety margins, and the cost advantages of leading companies like Muyuan are expected to expand [34][35] Summary by Sections Slaughter Volume - In January, the total slaughter volume of 18 sample pig companies was 18.02 million heads, with a year-on-year increase of 12.54% and a month-on-month decrease of 11.15% [6][9][11] Selling Price - The average selling price of commercial pigs in January was 12.58 yuan/kg, down 19.30% year-on-year but up 8.83% month-on-month [13][14][16] Average Weight - The average weight of slaughtered pigs was 121.41 kg in January, reflecting a year-on-year increase of 2.82% and a month-on-month increase of 1.42% [16][17][19] Industry Overview - The industry is facing a return to losses in breeding profits, with the average weight of pigs remaining high historically [19][20][34] Investment Recommendations - The report suggests a forward-looking layout at the bottom, emphasizing efficiency over growth and quality over scale, with a focus on companies like Muyuan, Wens, Dekang, and Shennong [33][34][35]

Investment Rating - The report maintains a positive outlook on the blood products industry, suggesting that the supply-demand relationship will gradually improve, leading to performance recovery for companies in this sector [10][34]. Core Insights - The blood products industry is characterized by a clear long-term growth trajectory, supported by a favorable regulatory environment for plasma collection and an expanding product range among companies [12][34]. - Short-term performance has been impacted by supply-demand mismatches, with a notable decline in profitability observed in 2025 due to excess supply and price reductions [19][36]. - The report highlights the importance of white albumin and immunoglobulin (IVIG) as core products, with a stable demand expected despite recent price pressures [33][34]. Summary by Sections Market Review - The report notes a decline of 0.85% in the medical index, underperforming the CSI 300 index by 1.22 percentage points, ranking 21st among 30 sectors [6]. - The top-performing stocks in the medical sector include Aidi Te, Zhendai Medical, and Olin Bio, while the worst performers include Beixin Life and Huayuan Bio [6]. Industry and Stock Events - The report emphasizes the recovery of plasma collection activities post-pandemic, which has led to increased supply and a shift in the market dynamics for blood products [19][26]. - The report identifies key companies to watch, including Tian Tan Biological and Bo Ya Biological, as they are expected to benefit from the industry's growth [12][34]. Overall Perspective and Investment Themes - The report suggests focusing on innovative drugs, medical devices, and the blood products sector, highlighting the potential for significant growth driven by domestic differentiation and international expansion [10][12]. - The report also discusses the ongoing consolidation in the industry, particularly among state-owned enterprises, which may enhance market concentration and operational efficiencies [46]. Supply and Demand Dynamics - The report indicates that the supply of blood products is expected to tighten in 2026 due to a slowdown in plasma collection growth and a decrease in imported white albumin supply [30][34]. - Demand for white albumin remains robust, with sales showing signs of stabilization despite recent challenges [33][34]. Future Outlook - The report anticipates a gradual return to a balanced supply-demand relationship in the blood products industry, which could lead to improved financial performance for key players [34][36]. - The potential for new product introductions and market expansions is highlighted as a significant driver for future growth in the sector [12][34].

Investment Rating - The report maintains a positive outlook on the blood products industry, suggesting that the sector has clear long-term growth potential due to increasing supply and demand elasticity [12][19][36]. Core Insights - The blood products industry is expected to benefit from a more relaxed approval process for plasma collection stations during the 14th Five-Year Plan, leading to increased production capacity and a diverse range of products [12][19]. - The report highlights a significant shift in the industry from a supply surplus to a supply-demand balance, with expectations for improved performance in 2026 as supply constraints tighten and demand remains stable [36][34]. - Key companies to watch include TianTan Biotech, BoYa Bio, and HuaLan Bio, which are expected to see performance improvements as the market stabilizes [12][36]. Summary by Sections Market Review - The report notes that the CITIC pharmaceutical index fell by 0.85%, underperforming the CSI 300 index by 1.22 percentage points, ranking 21st among 30 primary industries [6]. - The top-performing stocks in the sector included AidiTe and ZhenDe Medical, while stocks like BeiXin Life and HuaYuan Bio faced significant declines [6][12]. Industry and Stock Events - The blood products sector has experienced a prolonged adjustment period, with a cumulative decline of 18.1% since early 2025, significantly underperforming the broader pharmaceutical sector [16]. - The report indicates that the performance of major blood product companies has varied, with some like WeiGuang Bio and HuaLan Bio performing better than the sector average [16]. Overall Perspective and Investment Themes - The report emphasizes the transition from a quantity-driven to a quality-driven approach in the innovative drug sector, suggesting a focus on differentiated products and international expansion [10]. - In the medical device sector, there is a notable recovery in bidding volumes for imaging equipment, with companies like MaiRui and LianYing expected to benefit from ongoing upgrades [10]. - The report also highlights the importance of the CXO and life sciences services sectors, predicting a recovery in domestic investment and a return to high growth rates [10]. Blood Products - The blood products industry is characterized by a clear growth trajectory, with both supply and demand expected to show significant elasticity [12][19]. - The report suggests that the industry will see improved performance due to a combination of increased plasma collection and a tightening supply situation, which is expected to stabilize prices and enhance profitability for key players [36][34].

Group 1: Current Financial Data Analysis - In January 2026, the M2 growth was strong, with an increase of 3.6 trillion yuan month-on-month, ranking second highest in the observed data range, only behind 2024[17] - The growth of corporate deposits in January was exceptionally strong, with an increase of 1.4 trillion yuan month-on-month, representing 113% of the total increase for the previous year, the highest in the observed data range[19] - Non-bank deposits increased by 1.8 trillion yuan month-on-month, ranking second highest in the observed data range, with the increase accounting for approximately 21% of the total increase for the previous year[24] Group 2: Future Liquidity Outlook - Future liquidity appears to rely heavily on policy support, with weak consumer borrowing and direct financing through non-bank sectors[63] - The upcoming maturity of interbank certificates of deposit is expected to gradually decrease, which may impact liquidity levels[63] - The current liquidity easing is a fact, but under the "exit from unconventional" policy context, a marginal weakening of liquidity in 2026 compared to 2025 is likely[63] Group 3: Market Impact - The financial data does not yet provide a robust judgment on the recovery of domestic demand, indicating a continued reliance on exports[65] - The relationship between stocks and bonds remains unchanged, with the peak of the Shanghai Composite Index in January aligning with the peak of the ten-year government bond yield[65] - The bottom of bond yields is clearer than the top, as the probability of unconventional monetary easing by the central bank gradually decreases[65]